Table 1.
Patient characteristics
| Total patient group (n = 101) |
Pulmonary hypertensiona (n = 30) | No pulmonary hypertensiona (n = 71) |
p-value | |
|---|---|---|---|---|
| Age (years) | 65.9 (23–98) | 70.9 (23–87) | 63.9 (32–98) | 0.019 |
| Sex (male) | 68/101 (67.3%) | 19/30 (63.3%) | 49/71 (69.0%) | 0.645 |
| BMI (kg/m2) | 27.0 (16–47) | 27.1 (16–47) | 26.9 (19–38) | 0.372 |
| Inpatient | 80/101 (79.2%) | 24/30 (80%) | 56/71 (78.9%) | 1.000 |
| Hospital stay (days) | 21 (1–104) | 18 (1–70) | 22 (1–104) | 0.476 |
| ICU admission | 30/101 (29.7%) | 11/30 (36.7%) | 19/71 (26.8%) | 0.347 |
| Artificial ventilation | 16/101 (15.8%) | 7/30 (23.3%) | 9/71 (12.7%) | 0.149 |
| Time between COVID-19 diagnosis and echocardiography (days) | 63 (0–196) | 39 (0–176) | 73 (2–196) | 0.003 |
| – Inpatient | 30 (0–115) | 19 (0–100) | 38 (2–115) | 0.019 |
| – Outpatient | 98 (2–196) | 80 (2–176) | 102 (10–196) | 0.229 |
| Mortality | 19/101 (18.8%) | 10/30 (33.3%) | 9/71 (12.7%) | 0.015 |
| Indications for echocardiography | ||||
| – (Suspicion of) Heart failure | 53/101 (52.5%) | 19/30 (63.3%) | 34/71 (47.9%) | 0.175 |
| – Other/unknown | 48/101 (47.5%) | 11/30 (36.7%) | 37/71 (52.1%) | 0.295 |
BMI body mass index, ICU intensive care unit
aAs estimated by echocardiography